Precision BioSciences Files More Lawsuits Against Cellectis Alleging Patent Infringement | GenomeWeb

By a GenomeWeb staff reporter

NEW YORK (GenomeWeb News) – Precision BioSciences today announced that it has filed two more patent infringement lawsuits against French firm Cellectis.

The lawsuits were filed in US District Court for the Eastern District of North Carolina and allege Cellectis infringes US Patent Nos. 8,119,381 and 8,119,361. The patents relate to Precision Bio's Directed Nuclease Editor genome engineering technology.

Get the full story

This story is free
for registered users

Registering provides access to this and other free content.

Register now.

Already have an account?
Login Now.

Theresa May tries to reassure researchers about the UK's commitment to science, New Scientist reports.

In Science this week: new single-cell RNA sequencing technique to study proliferating cells, and more.

South African researchers uncover bone cancer in an ancient hominin ancestor.

English bulldogs suffer from low genetic diversity and might have to be outbred to improve their health, according to a new study.